FDA Should Consider New Lead Level Tests, Label Requirements – Advisers

Drug and dietary supplement manufacturers may need to include lead information on labels and use more sensitive test methods for lead levels in products if FDA follows the suggestions of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology